First test: how kidneys handle new medicine
NCT ID NCT07227922
Summary
This early-stage study aims to understand how a new drug called clofutriben is processed by the body in people with moderate kidney problems. It will compare 8 participants with kidney impairment to 8 healthy participants. The main goal is to see if the drug's levels in the blood are affected by reduced kidney function, which is a key safety step before wider testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Orlando Clinical Research Center
RECRUITINGOrlando, Florida, 32809, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.